1. Home
  2. IMXI vs ALLO Comparison

IMXI vs ALLO Comparison

Compare IMXI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • ALLO
  • Stock Information
  • Founded
  • IMXI 1994
  • ALLO 2017
  • Country
  • IMXI United States
  • ALLO United States
  • Employees
  • IMXI N/A
  • ALLO N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IMXI Technology
  • ALLO Health Care
  • Exchange
  • IMXI Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • IMXI 302.5M
  • ALLO 277.8M
  • IPO Year
  • IMXI N/A
  • ALLO 2018
  • Fundamental
  • Price
  • IMXI $10.30
  • ALLO $1.30
  • Analyst Decision
  • IMXI Buy
  • ALLO Strong Buy
  • Analyst Count
  • IMXI 7
  • ALLO 9
  • Target Price
  • IMXI $19.60
  • ALLO $8.44
  • AVG Volume (30 Days)
  • IMXI 318.6K
  • ALLO 3.2M
  • Earning Date
  • IMXI 08-06-2025
  • ALLO 08-06-2025
  • Dividend Yield
  • IMXI N/A
  • ALLO N/A
  • EPS Growth
  • IMXI 1.60
  • ALLO N/A
  • EPS
  • IMXI 1.70
  • ALLO N/A
  • Revenue
  • IMXI $652,547,000.00
  • ALLO N/A
  • Revenue This Year
  • IMXI N/A
  • ALLO N/A
  • Revenue Next Year
  • IMXI $3.03
  • ALLO $199.63
  • P/E Ratio
  • IMXI $6.02
  • ALLO N/A
  • Revenue Growth
  • IMXI N/A
  • ALLO N/A
  • 52 Week Low
  • IMXI $9.76
  • ALLO $0.86
  • 52 Week High
  • IMXI $22.38
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 45.01
  • ALLO 46.23
  • Support Level
  • IMXI $10.22
  • ALLO $1.13
  • Resistance Level
  • IMXI $10.87
  • ALLO $1.26
  • Average True Range (ATR)
  • IMXI 0.34
  • ALLO 0.08
  • MACD
  • IMXI 0.05
  • ALLO -0.00
  • Stochastic Oscillator
  • IMXI 48.65
  • ALLO 43.18

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: